- Home
- ABVC vs IPSC Comparison
ABVC vs IPSC Comparison
Compare ABVC & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVC
- IPSC
- Stock Information
- Founded
- ABVC 2015
- IPSC 2019
- Country
- ABVC United States
- IPSC United States
- Employees
- ABVC N/A
- IPSC N/A
- Industry
- ABVC Biotechnology: Pharmaceutical Preparations
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- ABVC Health Care
- IPSC Health Care
- Exchange
- ABVC Nasdaq
- IPSC Nasdaq
- Market Cap
- ABVC 52.1M
- IPSC 49.1M
- IPO Year
- ABVC N/A
- IPSC 2021
- Fundamental
- Price
- ABVC $2.84
- IPSC $0.54
- Analyst Decision
- ABVC
- IPSC Strong Buy
- Analyst Count
- ABVC 0
- IPSC 5
- Target Price
- ABVC N/A
- IPSC $3.33
- AVG Volume (30 Days)
- ABVC 70.7K
- IPSC 1.4M
- Earning Date
- ABVC 11-03-2025
- IPSC 11-07-2025
- Dividend Yield
- ABVC N/A
- IPSC N/A
- EPS Growth
- ABVC N/A
- IPSC N/A
- EPS
- ABVC N/A
- IPSC N/A
- Revenue
- ABVC $797,916.00
- IPSC $114,128,000.00
- Revenue This Year
- ABVC $735.18
- IPSC $1,589.94
- Revenue Next Year
- ABVC N/A
- IPSC N/A
- P/E Ratio
- ABVC N/A
- IPSC N/A
- Revenue Growth
- ABVC 56.52
- IPSC 5491.77
- 52 Week Low
- ABVC $0.40
- IPSC $0.34
- 52 Week High
- ABVC $5.48
- IPSC $1.83
- Technical
- Relative Strength Index (RSI)
- ABVC 46.98
- IPSC 44.71
- Support Level
- ABVC $2.75
- IPSC $0.55
- Resistance Level
- ABVC $3.03
- IPSC $0.65
- Average True Range (ATR)
- ABVC 0.15
- IPSC 0.04
- MACD
- ABVC -0.01
- IPSC -0.01
- Stochastic Oscillator
- ABVC 32.79
- IPSC 8.00
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.